Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal

Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal: A Community Based Cluster Randomized Controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05378438

Enrollment

1252

Registered

2022-05-18

Start date

2022-07-15

Completion date

2023-04-17

Last updated

2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccine Acceptance

Brief summary

This study is designed to assess the impact of the first introduction of microscope-based health education on people's attitude and practice towards disease prevention in Nepal, measured by vaccine acceptance rate. Such health education has an important role to play in communities where vaccine acceptance is low.

Interventions

OTHERMicrobe literacy Program in the form of workshop

Two to Three hours of workshop on microbe literacy will be conducted as an intervention. Workshop includes discussion on various common microorganisms causing diseases, their sources, relationship with surroundings and management. Prime focus of the session will be on management via treatments and risk reduction via vaccination.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* People aged 18 years or older who are resident of the study target area * People who stayed at least for 6 months on the area of study * People who agrees with the procedure of study and follow ups visits * People who provide consent for their participation will be recruited in the study.

Exclusion criteria

* People under 18 years of age will not be enrolled into study due to their limitation of understanding and implementation of the content of workshop given as intervention. * People who do not wish to participate in the trial * Those with currently ongoing court hearing and deprive of freedom will not be enrolled for the study.

Design outcomes

Primary

Measure	Time frame	Description
Differential vaccine acceptance rates between intervention and control group	Within 3 months of intervention	Data will be collected for baseline as well as post intervention after 3 months of workshop. For both the intervention and control group, number of vaccinated among the participants for provided COVID-19 vaccine and Typhoid vaccine will be made. Comparative analysis will be made in both the study groups before and after the intervention program.

Countries

Nepal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026